CNS Drugs provides researchers and healthcare professionals with essential information on the most important aspects of drug therapies used for the management of neurological and psychiatric disorders.

Via a program of reviews and original research articles, the journal addresses major issues relating to drug therapy of these disorders, including the pharmacology, efficacy and adverse effects of the major classes of drugs; information on newly developed drugs and drug classes; the therapeutic implications of latest research into the aetiology of neurological and psychiatric disorders; and the practical management of specific clinical situations.

As a hybrid journal, CNS Drugs does not charge authors to publish using the traditional subscription-based publishing route, but does offer the option to publish accepted articles open access if authors so wish or if their funders require. This is achieved via the Springer Open Choice™ initiative. More information about this optional route to open access and the associated article processing charge can be found by clicking on the ‘Learn about publishing Open Access with us’ link below.

CNS Drugs offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.

Journal information

Editors
  • Kate Palmer,
  • Susan Pochon
Publishing model
Hybrid. Learn about publishing Open Access with us

Journal metrics

5.749 (2020)
Impact factor
5.874 (2020)
Five year impact factor
30 days
Submission to first decision
103 days
Submission to acceptance
339,810 (2020)
Downloads

Latest articles

Journal updates

  • Digital Features

    CNS Drugs is able to host a range of digital features, with a number of options available to authors.

    Digital Features
View all updates

About this journal

Electronic ISSN
1179-1934
Print ISSN
1172-7047
Abstracted and indexed in
  1. ANVUR
  2. BFI List
  3. BIOSIS
  4. CLOCKSS
  5. CNKI
  6. CNPIEC
  7. Chemical Abstracts Service (CAS)
  8. Current Contents/ Life Sciences
  9. Current Contents/Clinical Medicine
  10. Dimensions
  11. EBSCO Academic Search
  12. EBSCO Advanced Placement Source
  13. EBSCO Biomedical Reference Collection
  14. EBSCO CINAHL
  15. EBSCO Discovery Service
  16. EBSCO Psychology & Behavioral Sciences Collection
  17. EBSCO Rehabilitation & Sports Medicine Source
  18. EBSCO SPORTDiscus
  19. EBSCO STM Source
  20. EMBASE
  21. Google Scholar
  22. Japanese Science and Technology Agency (JST)
  23. Journal Citation Reports/Science Edition
  24. Medline
  25. Naver
  26. OCLC WorldCat Discovery Service
  27. Pathway Studio
  28. Portico
  29. ProQuest Calcium and Calcified Tissue Abstracts
  30. ProQuest Central
  31. ProQuest Health & Medical Collection
  32. ProQuest Health Research Premium Collection
  33. ProQuest Medical Database
  34. ProQuest Natural Science Collection
  35. ProQuest Neurosciences Abstracts
  36. ProQuest Psychology Database
  37. ProQuest SciTech Premium Collection
  38. ProQuest-ExLibris Primo
  39. ProQuest-ExLibris Summon
  40. PsycINFO
  41. Reaxys
  42. SCImago
  43. SCOPUS
  44. Science Citation Index
  45. Science Citation Index Expanded (SciSearch)
  46. Semantic Scholar
  47. TD Net Discovery Service
  48. UGC-CARE List (India)
Copyright information

Rights and permissions

Springer policies

© Springer Nature Switzerland AG